SHL Group invests in new KraussMaffei molding machines for medical device production
October 2, 2013Manufacturing and Production auto injectors, autoinjector, pen injector, shl kraussmaffei
As SHL Group expands to provide customers with readily available services and production capabilities, the company insists on investing in …
Perjeta becomes first approved drug for early breast cancer
October 1, 2013Sales and Marketing FDA, Herceptin, Perjeta, Roche
Roche’s Perjeta has become the first preoperative breast cancer drug to be authorised by the FDA after it was granted …
MHRA: Cervarix ‘in clear’
October 1, 2013Sales and Marketing GSK, Gardasil, MHRA, ceravix
Cervarix, a key drug in the UK government’s human papillomavirus (HPV) vaccination programme, has been cleared of any involvement in …
Merck makes big changes at the top
October 1, 2013Medical Communications, Sales and Marketing Merck, Merck Serono
Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …
Aspen buys GSK plant and thrombosis drugs for $1.1 billion
October 1, 2013Manufacturing and Production, Sales and Marketing GSK, aspen
South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …
Cancer survival rates linked to government spending in EU
October 1, 2013Research and Development, Sales and Marketing CDF, Cancer, EU, NICE
The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …
Boehringer cancer drug impresses
October 1, 2013Research and Development, Sales and Marketing Boehringer, NSCLC, nintedanib
Boehringer Ingelheim has shown off its impressive oncology treatment nintedanib at the European Cancer Congress (ECC) in Amsterdam. The oral triple …
Eisai restates Halaven’s challenge to Roche’s Xeloda
September 30, 2013Research and Development, Sales and Marketing ECC, Halaven, Roche, Xeloda
Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …
Oliver Brandicourt joins Bayer from Pfizer
September 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Pfizer
Bayer Healthcare has appointed Pfizer’s executive Olivier Brandicourt to head up its healthcare division. Taking over from interim head Wolfgang …
Sanofi starts work on ‘largest African facility’
September 30, 2013Manufacturing and Production, Sales and Marketing Africa, Sanofi, algeria
Sanofi has started construction of a €70 million manufacturing facility in Algeria that will be the company’s largest site in …
Roche cancer treatment shows promise
September 30, 2013Sales and Marketing MPDL3280A, Merck Serono, NSCLC, Roche
An early-stage oncology treatment has shown encouraging results in smokers with lung cancer, Roche has said in a presentation at …
GSK in Barclays deal
September 30, 2013Sales and Marketing GSK, Zambia, barclays, csr
GlaxoSmithKline has signed a deal with banking giant Barclays in a bid to improve private sector health in Zambia, thus …
Cancer Drugs Fund to run until 2016
September 30, 2013Research and Development, Sales and Marketing CDF, Cameron, NHS, NICE, VBP
England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …
InVentiv Health makes strategic appointments
September 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentiv Health
Healthcare consultancy firm InVentiv Health has created two new positions
 to lead its growing business opportunities in Europe and Asia. …
The future of data disclosure in Europe
September 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, GSK, transparency
The debate of clinical trial transparency has at times appeared a peculiarly British issue, but plans are afoot in Europe …
Boehringer cuts ribbon on €70m addition to Shanghai plant
September 27, 2013Manufacturing and Production, Sales and Marketing Boehringer, China, Shanghai
Boehringer Ingelheim has officially opened the €70 million expansion of its facility in Zhangjiang, China, that is designed to triple …
NICE recommends ovarian cancer drug Caelyx
September 27, 2013Sales and Marketing NICE, Yondelis, ovarian cancer
Cancer Drugs Fund to stay, government to announce
September 27, 2013Medical Communications, Sales and Marketing CDF, Cameron, NHS, NICE, VBP, prime minister
The UK’s prime minister is set to announce that the controversial Cancer Drugs Fund will remain in place after March …
PM Society’s digital award winners announced
September 27, 2013Medical Communications, Sales and Marketing digital awards, pm society
The independent comms agency Ruder Finn and creative marketing shop Digitas Healthcare won most recognition at the PM Society Digital …
Novartis ‘sorry’ for Diovan data
September 27, 2013Sales and Marketing Japan, Novartis, diovan data
Novartis has apologised to patients in Japan over the alleged manipulation of data in five trials of its blockbuster blood …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
